2. Gene
  3. Caly - calcyon neuron-specific vesicular protein Gene

Caly - calcyon neuron-specific vesicular protein Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Mus musculus

同用名: Drd1ip; Calcyon; 0710001P07Rik; 1110004A22Rik

基因 ID: 68566 | 基因类型: protein coding

关于 Caly

功能概要

Predicted to enable clathrin light chain binding activity. Involved in postsynaptic neurotransmitter receptor internalization. Located in glutamatergic synapse. Is expressed in central nervous system; sensory organ; and skeleton. Human ortholog(s) of this gene implicated in attention deficit hyperactivity disorder. Orthologous to human CALY (calcyon neuron specific vesicular protein). [provided by Alliance of Genome Resources, Apr 2022]

Caly 基因产物(3)

mRNA Protein Name
NM_001190385.1 NP_001177314.1 neuron-specific vesicular protein calcyon
NM_001190386.1 NP_001177315.1 neuron-specific vesicular protein calcyon
NM_026769.5 NP_081045.2 neuron-specific vesicular protein calcyon
蛋白主名 其他名称

neuron-specific vesicular protein calcyon

calcyon

D1 dopamine receptor-interacting protein

dopamine receptor D1 interacting protein

相关产品

Approval
生物活性分子 (96)
目录号 产品名 作用方式
纯度 是否罕见病
HY-B0470 Neomycin sulfate Inhibitor 99.86% 否
HY-15244 Alpelisib Inhibitor 99.95% 是
HY-101562 Inavolisib 99.96% 否
HY-N0215 L-Phenylalanine Antagonist 99.98% 否
HY-10341 Fasudil Hydrochloride 99.97% 是
HY-A0057 Gabapentin Inhibitor 98.0% 是
HY-B0246 Carbamazepine 99.95% 是
HY-13764 Tetrandrine Inhibitor 99.90% 是
HY-B0782 Acetazolamide 99.85% 是
HY-B0561 Spironolactone 99.81% 是
HY-12542 Dantrolene Inhibitor 98.38% 是
HY-B0193A Prazosin hydrochloride 99.89% 否
HY-75161 (-)-Menthol Activator 99.79% 否
HY-70037 Cinacalcet Agonist 99.93% 是
HY-B1193 Terfenadine 99.98% 否
HY-B1221 Flufenamic acid 99.93% 否
HY-B1077 Penfluridol 99.93% 否
HY-B0632 Diltiazem Inhibitor 99.70% 是
HY-70037A Cinacalcet hydrochloride Agonist 99.98% 是
HY-17404 Cilnidipine Inhibitor 99.89% 是
HY-14656 Diltiazem hydrochloride Antagonist 99.47% 是
HY-14603 Clioquinol 99.84% 否
HY-N1370 Tanshinone IIA sulfonate sodium Inhibitor 99.77% 否
HY-15553A Mibefradil dihydrochloride Inhibitor 99.71% 是
HY-B1546A Benzamil hydrochloride Inhibitor 99.70% 否
HY-B0588 Brinzolamide Inhibitor 99.91% 否
HY-75839 Dronedarone Hydrochloride 99.99% 否
HY-10341A Fasudil 99.91% 是
HY-B0782A Acetazolamide sodium 99.54% 是
HY-A0057A Gabapentin hydrochloride Inhibitor 98.0% 是
HY-12542A Dantrolene sodium hemiheptahydrate Inhibitor 99.79% 否
HY-B0358A Flunarizine dihydrochloride 99.36% 是
HY-B0109A Dorzolamide hydrochloride Inhibitor 99.86% 是
HY-10932 Aniracetam Modulator 99.94% 否
HY-B1693 Levomepromazine 99.98% 否
HY-B0596 Taltirelin 99.91% 否
HY-14657 Dantrolene sodium Inhibitor 99.79% 是
HY-A0082 Diphenidol hydrochloride Antagonist 99.06% 否
HY-B0684 Iopamidol 99.85% 否
HY-B1424 Benzthiazide Inhibitor 99.70% 否
HY-B1154 Penbutolol sulfate Antagonist 98.89% 否
HY-16952A Bepridil hydrochloride hydrate Antagonist 99.86% 否
HY-B0473 Tetracaine hydrochloride Inhibitor 99.91% 否
HY-N0215R L-Phenylalanine (Standard) Antagonist 99.99% 否
HY-B0021 Doxifluridine Inhibitor 99.44% 否
HY-103370 Talniflumate Inhibitor 99.90% 是
HY-B1457 Ouabain / 否
HY-B0246R Carbamazepine (Standard) 99.97% 否
HY-B0380A Trimebutine maleate 99.91% 是
HY-Y0258A Benzocaine hydrochloride 99.83% 否
HY-B0380 Trimebutine 99.42% 是
HY-107929 Calcium polystyrene sulfonate / 否
HY-Z0478 (-)-Limonene Inhibitor 98.59% 否
HY-17613 Evocalcet Activator 99.28% 否
HY-B0551 Doxapram Inhibitor 99.70% 否
HY-B0551A Doxapram hydrochloride hydrate Inhibitor 99.28% 否
HY-U00212 Aranidipine Antagonist 99.12% 否
HY-107319 Almitrine mesylate Inhibitor 98.88% 否
HY-112961 Patiromer Inhibitor 95.0% 否
HY-121186 Bevantolol hydrochloride Antagonist 98.98% 是
HY-108974 Drotaverine hydrochloride 99.65% 否
HY-109545 Isopropyl unoprostone Activator 95.10% 否
HY-16216 Gabapentin enacarbil Inhibitor 95.0% 是
HY-P1769 Angiotensin II (5-8), human 99.74% 否
HY-A0135 Enflurane Inhibitor 98.0% 否
HY-A0236 Aprindine Inhibitor 98.43% 否
HY-B0562 Methyclothiazide 99.76% 否
HY-109106A Upacicalcet sodium Agonist 99.91% 否
HY-B0596A Taltirelin acetate 99.38% 否
HY-B1471 Fluorometholone acetate Inhibitor 98.54% 否
HY-15244R Alpelisib (Standard) Inhibitor 99.86% 否
HY-10341C Fasudil dihydrochloride 99.98% 是
HY-116790 (-)-Penbutolol Antagonist 99.74% 否
HY-128370 Calcium trinatrium diethylenetriaminepentaacetic acid hydrate Inhibitor 98.0% 否
HY-15553 Mibefradil Inhibitor / 否
HY-B0109 Dorzolamide Inhibitor / 否
HY-109106 Upacicalcet Agonist / 否
HY-150520 Neomycin Inhibitor / 否
HY-10341B Fasudil hydrochloride semihydrate / 否
HY-106916 Unoprostone Activator 99.0% 否
HY-121166 Levobetaxolol Antagonist / 否
HY-14656R Diltiazem hydrochloride (Standard) Antagonist / 否
HY-75839R Dronedarone Hydrochloride (Standard) / 否
HY-A0270 Diphenidol Antagonist / 否
HY-B0021R Doxifluridine (Standard) Inhibitor / 否
HY-B0109AR Dorzolamide hydrochloride (Standard) Inhibitor / 否
HY-B0193AR Prazosin hydrochloride (Standard) / 否
HY-B0401A Tolbutamide sodium Inducer / 否
HY-B0588A Brinzolamide hydrochloride Inhibitor / 否
HY-B0588R Brinzolamide (Standard) Inhibitor / 否
HY-B0632A Diltiazem malate Inhibitor / 否
HY-B1546 Benzamil Inhibitor / 否
HY-B1558 Bifemelane / 否
HY-P1792 Angiotensin II (1-4), human Agonist / 否
HY-P1792A Angiotensin II (1-4), human TFA Agonist / 否
HY-B1693R Levomepromazine (Standard) / 否
Clinical Phase
生物活性分子 (76)
目录号 产品名 作用方式
纯度 Phase
HY-N6687 Calcimycin 99.12% Phase 4
HY-N6687A Calcimycin hemicalcium salt / Phase 4
HY-N6687B Calcimycin hemimagnesium / Phase 4
HY-13898 Taselisib Inhibitor 99.75% Phase 3
HY-50694 Senicapoc Inhibitor 99.91% Phase 3
HY-10805 Almorexant 99.96% Phase 3
HY-17449 Fosbretabulin disodium 99.91% Phase 3
HY-15724 Vercirnon Antagonist 98.01% Phase 3
HY-10805A Almorexant hydrochloride 99.98% Phase 3
HY-145567 Fasedienol 99.68% Phase 3
HY-14797 Ombrabulin Inhibitor 98.53% Phase 3
HY-106449 Recoflavone 98.0% Phase 3
HY-18256 Ombrabulin hydrochloride Inhibitor 99.57% Phase 3
HY-Z7721 (Rac)-Beraprost sodium Inhibitor 99.0% Phase 3
HY-113970 Nebracetam / Phase 3
HY-15855 Fosbretabulin tromethamine Modulator / Phase 3
HY-118962 E913 / Phase 3
HY-10358 MK-2206 dihydrochloride 99.99% Phase 2
HY-50876 Daporinad 99.91% Phase 2
HY-N1584 Halofuginone 99.28% Phase 2
HY-13513 U-104 Inhibitor 99.95% Phase 2
HY-108232 MK-2206 99.72% Phase 2
HY-135317 Emavusertib 99.97% Phase 2
HY-10007 NPS-2143 Antagonist 99.94% Phase 2
HY-101064 Fmoc-leucine 99.91% Phase 2
HY-115864 Osavampator Activator 99.74% Phase 2
HY-N1584A Halofuginone hydrobromide 99.85% Phase 2
HY-P10798A Eloralintide sodium Inhibitor 99.72% Phase 2
HY-10167A Tecalcet Hydrochloride Modulator 99.43% Phase 2
HY-15293B JTV-519 hemifumarate Inhibitor 99.74% Phase 2
HY-10066 Nelivaptan Antagonist 99.89% Phase 2
HY-118467 Benzolamide Inhibitor 99.59% Phase 2
HY-100414 Soraprazan Inhibitor 99.78% Phase 2
HY-B0340 Nefiracetam Activator 99.91% Phase 2
HY-15724A Vercirnon sodium Antagonist 98.04% Phase 2
HY-147301 Resomelagon Agonist 98.79% Phase 2
HY-N0842 Bevirimat Inhibitor 99.82% Phase 2
HY-160023 Elisrasib 98.50% Phase 2
HY-100779 Rimacalib Inhibitor 99.14% Phase 2
HY-19721 ABT-639 Inhibitor 99.32% Phase 2
HY-147301A Resomelagon acetate Agonist 99.75% Phase 2
HY-100298 Caldaret Inhibitor 98.35% Phase 2
HY-100934 SC-9 Activator / Phase 2
HY-137459 Vocacapsaicin Agonist / Phase 2
HY-137459A Vocacapsaicin hydrochloride Antagonist 95.66% Phase 2
HY-135317B Emavusertib hydrochloride / Phase 2
HY-10357 MK-2206 free base / Phase 2
HY-10049 CP 122721 Antagonist / Phase 2
HY-105269A Org 30029 hydrochloride Activator / Phase 2
HY-106904 Nexopamil Antagonist / Phase 2
HY-110312 JTV-519 fumarate / Phase 2
HY-113037B Farnesyl pyrophosphate Agonist / Phase 2
HY-121535 Levosemotiadil Inhibitor / Phase 2
HY-169115 PD-0299685 / Phase 2
HY-19397 BMS-223131 / Phase 2
HY-106415 Terflavoxate Antagonist / Phase 2
HY-106927 Bay Y5959 Agonist / Phase 2
HY-114826S Prostaglandin E2-1-glyceryl ester-d5 Activator / Phase 2
HY-108496 Sphingosine-1-phosphate Agonist 99.54% Phase 1
HY-100973A Adenosine 5′-diphosphoribose sodium 99.47% Phase 1
HY-101093 CA-170 Inhibitor 99.39% Phase 1
HY-16935 Mavatrep Antagonist 99.67% Phase 1
HY-100886 BAY1082439 99.35% Phase 1
HY-107111 GSK1034702 Agonist 99.78% Phase 1
HY-NP009 α-Lactalbumin Inhibitor 99% Phase 1
HY-129851 NTP42 Antagonist 98.58% Phase 1
HY-126077 MTI-31 Inhibitor 99.98% Phase 1
HY-120588 BI 639667 Antagonist 98.87% Phase 1
HY-137849 RK-582 Inhibitor 98.05% Phase 1
HY-137458 Vevorisertib Inhibitor 98.03% Phase 1
HY-115681 (2R/S)-6-PNG Inhibitor 99.88% Phase 1
HY-133011 nAChR agonist 1 Agonist 98.35% Phase 1
HY-107111A GSK1034702 hydrochloride Agonist / Phase 1
HY-114793 AL-12180 Agonist / Phase 1
HY-118148 UK-66914 Inhibitor / Phase 1
HY-121701 SR33805 analog Antagonist / Phase 1
抗体抑制剂 (1)
目录号 产品名 作用方式
纯度 Phase
HY-P99409 Oregovomab 99.66% Phase 3
Pre-clinical Phase
生物活性分子 (970)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-18723 Yoda 1 99.97% 否
HY-13434 Ionomycin 99.27% 否
HY-13433 Thapsigargin 99.95% 否
HY-100545 BAPTA-AM Inhibitor 99.68% 否
HY-101896 Fluo-4 AM ≥99.0% 否
HY-W009724 2-Aminoethyl diphenylborinate 98.86% 否
HY-D0989 Rhod-2 AM ≥97.0% 否
HY-D0861 EGTA 98.0% 否
HY-N0219 Bicuculline Antagonist 99.97% 否
HY-100202 TPEN 99.91% 否
HY-13434A Ionomycin calcium 98.32% 否
HY-19608 GSK1016790A 99.93% 否
HY-100168 BAPTA Inhibitor 98.10% 否
HY-100350 CA-074 methyl ester Inhibitor 99.34% 否
HY-10588 Bay K 8644 Agonist 99.96% 否
HY-15084B Dizocilpine Antagonist 99.95% 否
HY-126010 Dooku1 Antagonist 99.93% 否
HY-103350 CA-074 Inhibitor 99.94% 否
HY-19805 STO-609 Inhibitor 98.20% 否
HY-12323 ISX-9 Activator 99.76% 否
HY-100831 YM-58483 Inhibitor 99.38% 否
HY-138620 MCU-i4 Inhibitor 99.87% 否
HY-101455 CDN1163 Activator 99.90% 否
HY-119287 TSQ 99.50% 否
HY-118630 Vacuolin-1 Inhibitor 98.54% 否
HY-100912 W-7 hydrochloride 99.96% 否
HY-P0221 PACAP (1-38), human, ovine, rat Inducer 99.99% 否
HY-D1024 Coelenterazine h 99.41% 否
HY-134923 CA77.1 Inducer 99.92% 否
HY-100560 Abscisic acid Inhibitor 99.73% 否
HY-101379A 8-Bromo-cGMP sodium Inhibitor 99.89% 否
HY-100001 SKF-96365 hydrochloride 99.93% 否
HY-Y0669 Pipecolic acid Inhibitor 99.92% 否
HY-153306 Zovegalisib Inhibitor 99.20% 否
HY-15754 CGP37157 Inhibitor 99.87% 否
HY-103312 Xestospongin C Inhibitor 99.9% 否
HY-P1410B D-GsMTx4 Inhibitor 99.59% 否
HY-113308A Taurolithocholic acid sodium salt Agonist 99.81% 否
HY-123071 Box5 Antagonist 99.24% 否
HY-D1498 Mag-Fluo-4 AM 96.0% 否
HY-101897 Fura-2 AM ≥99.0% 否
HY-103319 Calmidazolium chloride Antagonist 99.94% 否
HY-D0973 EGTA-AM 99.77% 否
HY-N6732 K-252a Inhibitor 99.45% 否
HY-P0256 Apamin Inhibitor 99.96% 否
HY-120691A GSK205 Antagonist 99.47% 否
HY-P1410C D-GsMTx4 TFA Inhibitor 99.89% 否
HY-N0215S12 L-Phenylalanine-d5 Antagonist 99.90% 否
HY-D0716 Fluo-3AM ≥99.0% 否
HY-116330A Hyperforin dicyclohexylammonium salt 99.48% 否
HY-101044 PPADS tetrasodium 99.9% 否
HY-131614 TPC2-A1-N Inhibitor 99.86% 否
HY-108599 DCP-LA 98.0% 否
HY-15515 SEA0400 Inhibitor 99.95% 否
HY-W019981B Magnesium chloride hexahydrate, for molecular biology Activator 99.40% 否
HY-113037C Farnesyl pyrophosphate ammonium Agonist 95.39% 否
HY-N1502 Carboxyatractyloside tripotassium 99.97% 否
HY-107859 Tris(2-chloroethyl) phosphate 97.07% 否
HY-116522 AR420626 98.29% 否
HY-107543 8-pCPT-2′-O-Me-cAMP sodium Activator 99.81% 否
HY-P0033 Argireline Inhibitor 99.77% 否
HY-103192 MDL12330A Inhibitor 99.82% 否
HY-108465 Pyr3 Inhibitor 99.83% 否
HY-15124 (S)-(-)-Bay-K-8644 Agonist 99.10% 否
HY-135897 Urolithin C 98.00% 否
HY-W127512 5β-Cholanic acid 99.87% 否
HY-113328 Aminoadipic acid 99.86% 否
HY-133168 Englerin A Activator 99.50% 否
HY-N6778 Paxilline Inhibitor 99.91% 否
HY-123071A Box5 TFA Antagonist 99.24% 否
HY-157131 TRPV2-selective blocker 1 Inhibitor 99.84% 否
HY-N6789 KT5720 Inhibitor ≥99.0% 否
HY-N0043 Ginsenoside Rd Inhibitor 99.88% 否
HY-101017 Palmitoylcarnitine chloride 98.0% 否
HY-W019981C Magnesium chloride hexahydrate, for cell culture Activator / 否
HY-15415 KB-R7943 mesylate Inhibitor 99.16% 否
HY-12949 ML204 Inhibitor 98.45% 否
HY-101906 DC260126 99.74% 否
HY-103474 Bicuculline methiodide Inhibitor 99.93% 否
HY-107411 Bromoenol lactone Inhibitor 99.59% 否
HY-110105 NS8593 hydrochloride Inhibitor 99.76% 否
HY-116429 Maresin 1 Inhibitor 99.00% 否
HY-100168B BAPTA tetrapotassium Inhibitor 99.45% 否
HY-P5712 Gramicidin S Inhibitor 99.89% 否
HY-15416 NS309 Activator 99.09% 否
HY-N2522 Carboxyatractyloside dipotassium 99.57% 否
HY-103660 18:0 LYSO-PE 99.0% 否
HY-I0096 Indole-2-carboxylic acid 99.86% 否
HY-W194810 MCU-i11 98.42% 否
HY-B2149 Quadrol Activator 99.88% 否
HY-16697 CID 16020046 Antagonist 99.81% 否
HY-119401 CAY10444 Antagonist 98.0% 否
HY-14229 TGR5 Receptor Agonist Agonist 99.71% 否
HY-P1345A TLQP-21 TFA Agonist 99.84% 否
HY-111208 CCT129957 Inhibitor 99.71% 否
HY-121119 MRS 1523 99.97% 否
HY-13103 NS 11021 Activator 99.51% 否
HY-149662 TMDJ-035 Inhibitor 99.92% 否
HY-162501 Yaddle1 Agonist 99.14% 否
HY-P6292A KS-133 TFA Antagonist 99.27% 否
HY-N0515 Ophiopogonin D 99.80% 否
HY-P0189A ω-Conotoxin GVIA TFA Inhibitor 99.03% 否
HY-Y0413 Biacetyl monoxime Inhibitor 98.0% 否
HY-Y1667 2,6-Dibromophenol Inhibitor 99.76% 否
HY-33299 Serpin B9-IN-1 97.42% 否
HY-19408 Pyr10 Inhibitor 99.95% 否
HY-107658 SN 6 Inhibitor 99.79% 否
HY-120261 GB-88 Inhibitor 98.66% 否
HY-N0607 Ginsenoside Ro 99.81% 否
HY-P1080A ω-Agatoxin IVA TFA Inhibitor 99.10% 否
HY-131648 1-Oleoyl-2-acetyl-sn-glycerol Activator 99.90% 否
HY-120072 PF-3450074 Inhibitor 98.89% 否
HY-114252 Strophanthidin Inhibitor 98.53% 否
HY-N0215S8 L-Phenylalanine-13C6 Antagonist 99.8% 否
HY-N0601 Ginsenoside Rf Inhibitor 99.48% 否
HY-103307 FPL64176 Agonist 99.86% 否
HY-162426 UNC-CA2-103 Inhibitor 99.26% 否
HY-P0190 Iberiotoxin Inhibitor 99.71% 否
HY-P3278A Caloxin 2A1 TFA Inhibitor 99.92% 否
HY-100168A BAPTA tetrasodium Inhibitor 99.70% 否
HY-126750 GNF362 Inhibitor 99.86% 否
HY-103306 Ryanodine Inhibitor 99.91% 否
HY-D1903 Fura Red AM 91.00% 否
HY-12496 NS-1619 98.06% 否
HY-103309 ML218 Inhibitor 99.49% 否
HY-16690 BTS Inhibitor 99.79% 否
HY-B0358 Flunarizine 99.93% 是
HY-157562 DS68591889 99.18% 否
HY-136409 N-Decanoyl-L-homoserine lactone 98.40% 否
HY-137790 Bicuculline methochloride Antagonist 99.80% 否
HY-15292 S107 Ligand 99.77% 否
HY-P2847 Urocortin II, mouse Agonist 98.66% 否
HY-P3278 Caloxin 2A1 Inhibitor 99.86% 否
HY-10171 NPS-2143 hydrochloride Antagonist 99.98% 否
HY-106844A (+)-EMD 57033 Agonist 99.72% 否
HY-124416 ML604086 Inhibitor 99.78% 否
HY-16689 VU 0240551 Inhibitor 99.70% 否
HY-W048457 Palladium hydroxide on activated carbon(20%)(wetted with ca. 55% Water) Control ≥97.0% 否
HY-N0215S1 L-Phenylalanine-d8 Antagonist 99.90% 否
HY-B0782R Acetazolamide (Standard) 99.69% 否
HY-N2500 Deoxypodophyllotoxin 99.87% 否
HY-P0190A Iberiotoxin TFA Inhibitor 99.43% 否
HY-N15721 Tryptophan-cholic acid 99.75% 否
HY-112698 CA-5f 99.14% 否
HY-110243 CAIX Inhibitor S4 Inhibitor 99.04% 否
HY-B0006C (R)-Carvedilol Inhibitor 98.78% 否
HY-N0126 Xanthone Inhibitor 99.97% 否
HY-101360 1-EBIO Agonist 99.96% 否
HY-N0910 Notoginsenoside Ft1 99.49% 否
HY-18071 BI-9627 Inhibitor 99.71% 否
HY-N0252 Catharanthine Inhibitor 99.65% 否
HY-N2344 Procyanidin A1 Inhibitor 99.96% 否
HY-120026 KB130015 98.45% 否
HY-120528A GB-110 hydrochloride Agonist 99.86% 否
HY-16992A W-54011 99.57% 否
HY-101015A OBAA 99.31% 否
HY-103316A Ned 19 Inhibitor 99.92% 否
HY-12759 CARM1-IN-1 Inhibitor 95.0% 否
HY-103320A Calhex 231 hydrochloride Inhibitor 99.81% 否
HY-16639 ML314 Agonist 99.52% 否
HY-101366 A-61603 Agonist 99.16% 否
HY-120597 SAK3 Activator 99.80% 否
HY-14350 AC-55541 Agonist 99.40% 否
HY-15671 GKA50 Activator 99.84% 否
HY-160099 20-5,14-HEDE 98.34% 否
HY-N4104 Agaric acid 99.45% 否
HY-130118 MRGPRX1 agonist 1 Agonist 99.95% 否
HY-100712 DPO-1 Inhibitor 98.39% 否
HY-108593 BMS-191011 Activator 99.56% 否
HY-D1422 ER Tracker Yellow 96.91% 否
HY-P1366 des-​Gln14-​Ghrelin 99.66% 否
HY-P1821 Myelin Basic Protein 99.55% 否
HY-118010A (+)-Norfenfluramine hydrochloride Agonist 99.77% 否
HY-B1671 (+)-Kavain 99.98% 否
HY-W131725 (+)-Norfenfluramine Agonist 99.92% 否
HY-101329 Anthracene-9-carboxylic acid Inhibitor 99.09% 否
HY-110153 NS19504 Activator 99.93% 否
HY-12927 SX-517 Antagonist 99.90% 否
HY-136460 Calcium ionophore I 99.6% 否
HY-34740 Ethylmalonic acid Inhibitor 98.0% 否
HY-N6701 Dihydrocytochalasin B 99.0% 否
HY-NP164 Concanavalin A-HRP / 否
HY-P3965 16-38-Thymosin β4 (cattle) Activator 98.05% 否
HY-N0215S10 L-Phenylalanine-13C9 Antagonist 98.09% 否
HY-N7848 Linoleamide Inhibitor 99.4% 否
HY-114400 TRPV4 agonist-1 free base Agonist 99.69% 否
HY-108464A Phenamil methanesulfonate Inhibitor 98.1% 否
HY-129440 N-(p-Coumaroyl) Serotonin Inhibitor 99.03% 否
HY-D1024A Coelenterazine h hydrochloride 98.80% 否
HY-N0084 Betulinaldehyde Inhibitor 98.72% 否
HY-N0215S5 L-Phenylalanine-15N Antagonist 98.10% 否
HY-N7690 3,5,7,3′,4′-Pentamethoxyflavone Inhibitor 99.69% 否
HY-N8307 Syringaresinol 99.66% 否
HY-P10655 Caloxin 1C2 Inhibitor 99.47% 否
HY-W001538 S-Propargylcysteine ≥97.0% 否
HY-W041308 DCOIT Agonist 99.87% 否
HY-108607 PACOCF3 Inhibitor 98.0% 否
HY-115719 NR162 Inhibitor 99.7% 否
HY-116291 4α-Phorbol 12,13-didecanoate 99.30% 否
HY-124873 SERCA2a activator 1 Activator 99.71% 否
HY-162774A GRP75-IN-1 dihydrochloride Inducer 99.75% 否
HY-E70200 Recombinant Kex2 protease / 否
HY-N2081 Skimmianine Inhibitor 99.90% 否
HY-P1075 CALP3 Inhibitor 99.55% 否
HY-W110910 Eriochrome black T, Indicator / 否
HY-32933 4-Acetylphenylboronic acid Inhibitor 99.96% 否
HY-12498 GV-58 Agonist 99.22% 否
HY-100783 (-)-Bicuculline methobromide Antagonist 99.94% 否
HY-104058 BAPTA Green 1AM 92.0% 否
HY-135891 AZD2423 Antagonist 99.91% 否
HY-145542 Isovalerylcarnitine chloride Activator 99.48% 否
HY-P1821A Myelin Basic Protein TFA 99.41% 否
HY-157453 CCR4 antagonist 4 Antagonist 99.72% 否
HY-D0861A EGTA tetrasodium 99.93% 否
HY-101396 ICA-069673 Activator 99.20% 否
HY-100656 Desmethyl cariprazine Antagonist 98.08% 否
HY-103317 NAADP 95.8% 否
HY-103442 CGP52411 Inhibitor 99.82% 否
HY-108608 o-3M3FBS 99.88% 否
HY-129126 NC9 Inhibitor 99.98% 否
HY-136661 (-)-N6-Phenylisopropyl adenosine Agonist 99.45% 否
HY-136909 SR33805 Antagonist 99.78% 否
HY-34740S Ethylmalonic acid-d3 Inhibitor 98.0% 否
HY-N0215S3 L-Phenylalanine-d2 Antagonist 99.00% 否
HY-N2060 Evocarpine 99.88% 否
HY-P1076A CALP2 TFA Antagonist 98.31% 否
HY-P1077A CALP1 TFA 99.86% 否
HY-P3089A Dendrotoxin K TFA Inhibitor 99.54% 否
HY-W181102 NFAT Inhibitor-2 Inhibitor 98.42% 否
HY-12949A ML204 hydrochloride Inhibitor 99.74% 否
HY-125703 Ferutinin 99.23% 否
HY-158779 Sulfane sulfur probe 4 97.3% 否
HY-D0202 Arsenazo III 95.0% 否
HY-N7063 Nerol 98.97% 否
HY-N7575 Lacto-N-fucopentaose II 98.0% 否
HY-P0188A ω-Conotoxin MVIIC TFA Inhibitor 99.43% 否
HY-P1831 Proadrenomedullin (1-20), human 99.67% 否
HY-W749867 Ca(II)-EDTA disodium dihydrate 99.9% 否
HY-101087 Benzenesulphonamide Inhibitor 99.75% 否
HY-108496S Sphingosine-1-phosphate-d7 Agonist 99.9% 否
HY-117073 ITH12575 Inhibitor 98.58% 否
HY-124594 CA inhibitor 1 Inhibitor 99.77% 否
HY-135746 OR-1896 99.04% 否
HY-136190 TRPC6-PAM-C20 Agonist 99.78% 否
HY-145127 ETZ 99.84% 否
HY-175416 Yoda2 99.57% 否
HY-N0215S11 L-Phenylalanine-13C9,15N Antagonist 99.52% 否
HY-N0215S7 L-Phenylalanine-3-13C Antagonist 99.56% 否
HY-N6688 Verruculogen Inhibitor 98.08% 否
HY-P1247 Calcineurin autoinhibitory peptide Inhibitor 99.99% 否
HY-P3187 exo-β-1,4-Xylosidase, Cellulosimicrobium cellulans sp. 21 / 否
HY-P4160 PDC31 Inhibitor 99.92% 否
HY-P5189A His-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2 TFA 99.56% 否
HY-W010710 IPrAuCl Inhibitor 98.0% 否
HY-W012399 2,5-Di-tert-butylhydroquinone 99.90% 否
HY-N7491A Ent-(+)-Verticilide Inhibitor 99.91% 否
HY-137175 TMBIM6 antagonist-1 Antagonist 98.92% 否
HY-100928 YS 035 hydrochloride Antagonist 99.15% 否
HY-103277A BIM 23042 TFA Antagonist 96.20% 否
HY-108592 UCL 2077 Inhibitor 98.91% 否
HY-121584 Lycoperodine-1 Agonist 99.82% 否
HY-136182 YM-244769 dihydrochloride Inhibitor 98.57% 否
HY-136980 Aspartylglutamate 99.79% 否
HY-B0782S Acetazolamide-d3 Inhibitor 99.73% 否
HY-N2157 Pteryxin Inhibitor 99.55% 否
HY-P0271A Syntide 2 TFA 99.22% 否
HY-P2757 Phosphorylase kinase / 否
HY-W111226 Fmoc-His(3-Me)-OH Inhibitor 99.67% 否
HY-107859S Tris(2-chloroethyl)phosphate-d12 99.15% 否
HY-N0215S2 L-Phenylalanine-13C Antagonist 99.66% 否
HY-12759A CARM1-IN-1 hydrochloride Inhibitor 95.13% 否
HY-105118A Zaldaride maleate Antagonist 99.7% 否
HY-165607S MCB-22-174 99.78% 否
HY-103317A NAADP tetrasodium 95.8% 否
HY-128678 ORM-10103 Inhibitor 99.43% 否
HY-13338 Mabuterol Agonist 99.96% 否
HY-136182A YM-244769 Inhibitor 99.22% 否
HY-146268 CaMKIIα-IN-1 Inhibitor 98.53% 否
HY-161104 Kv2.1-IN-1 Inhibitor 98.64% 否
HY-A0236A Aprindine hydrochloride Inhibitor 98.96% 否
HY-D0110A Fura-2 pentapotassium 97.0% 否
HY-N1584C Halofuginone lactate 98.32% 是
HY-N7117 1,4-Cineole Activator 95.0% 否
HY-NP164B Concanavalin A-AF488 / 否
HY-P0256A Apamin TFA Inhibitor 97.03% 否
HY-P1250 RFRP-3(human) Agonist 99.43% 否
HY-P3617 Glucagon (22-29) Agonist 99.69% 否
HY-W074975 CL 5343 Inhibitor 99.91% 否
HY-41076 Ca2+ channel agonist 1 98.87% 否
HY-100402 CFMTI Antagonist 98.0% 否
HY-103320B (1R,2R)-Calhex 231 hydrochloride Control 98.45% 否
HY-11000A CaMKP inhibitor sodium Inhibitor 98.06% 否
HY-110140 (E)-KN-93 phosphate Inhibitor 99.85% 否
HY-111527 PPZ2 99.92% 否
HY-126583 Nemadipine-A Inhibitor 98.0% 否
HY-149483 CVN417 Antagonist 99.93% 否
HY-151917 Enpp/Carbonic anhydrase-IN-2 Inhibitor 98.48% 否
HY-155480 PSB-22034 Agonist 99.61% 否
HY-15705 GPR35 agonist 2 98.61% 否
HY-176550 ASIC1a antagonist-1 Antagonist 98.00% 否
HY-B0493S1 Niflumic acid-13C6 Inhibitor 99.8% 否
HY-P3037A Imperatoxin A TFA Activator 98.65% 否
HY-P5914A Wasabi Receptor Toxin TFA Activator 99.49% 否
HY-W641445 ELP-004 Inhibitor 99.89% 否
HY-126789A DM-Nitrophen tertasodium 90.0% 否
HY-N0742 Absinthin Agonist 98.0% 否
HY-W010252 N-Benzylethylenediamine / 否
HY-14656S Diltiazem-d3 hydrochloride Antagonist 98.70% 否
HY-103078 I-XW-053 Inhibitor 99.71% 否
HY-103308 TRAM-39 Inhibitor 99.66% 否
HY-103472 FPR-A14 Agonist 98.58% 否
HY-103544 [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P 98.48% 否
HY-10388A TTA-Q6(isomer) 99.91% 否
HY-106784A (E)-Ajoene 95% 否
HY-110292 A-425619 99.96% 否
HY-119282 AZD6538 Inhibitor / 否
HY-121825 U-44069 Control 98.0% 否
HY-129496 NP-313 Inhibitor 99.58% 否
HY-131012 GoSlo-SR-5-69 Activator 99.26% 否
HY-131948 3-Chlorodiphenylamine Activator 98.74% 否
HY-13699 NBI-42902 98.65% 否
HY-155516 KV1.3-IN-1 Inhibitor 98.34% 否
HY-15809 (Rac)-Ibrutinib alkyne Inhibitor 99.35% 否
HY-165473 Hexadecylphosphoserine Activator / 否
HY-165473A Hexadecylphosphoserine TFA Activator 98.0% 否
HY-173537 D-myo-Inositol-1,2,4,5-tetraphosphate tetrasodium salt 98% 否
HY-174140 VU0514009 Antagonist 99.53% 否
HY-18071A BI-9627 hydrochloride Inhibitor 98.01% 否
HY-76779 4-(Chloromethyl)-7-hydroxycoumarin 98.01% 否
HY-B1221S1 Flufenamic acid-13C6 99.5% 否
HY-D1631 Calcium Green-5N AM / 否
HY-DY1020 Rhod-2 AM (solution) / 否
HY-E70197A Calpain-1, Human Erythrocyte Modulator / 否
HY-E70234A Sortase A, S. aureus (non-Ca2+-dependent) 96.9% 否
HY-N2005 Cycleanine 99.80% 否
HY-N4237 Saikogenin D 99.99% 否
HY-N5130 Effusol Inhibitor 99.83% 否
HY-N9404 6-Benzoylheteratisine Inhibitor 98.17% 否
HY-P1077 CALP1 98.44% 否
HY-P1387 β-Amyloid (1-40) (rat) Inducer 99.58% 否
HY-P1397A RVD-Hpα TFA Agonist 99.32% 否
HY-P1640 (Trp63,Trp64)​-​C3a(63-77) Agonist 99.23% 否
HY-P1805 Calmodulin Binding Peptide 1 Inhibitor 98.68% 否
HY-P3811A Autocamtide-3 acetate 99.95% 否
HY-W013857 Lavendustin C Inhibitor 98.32% 否
HY-126789 DM-Nitrophen 98.40% 否
HY-150135B D-myo-Inositol 1,4,5-trisphosphate tripotassium Activator 98.00% 否
HY-111207 CA224 99.94% 否
HY-B0124S Zonisamide-d4 Inhibitor 99.38% 否
HY-145456 Gallium 8-Hydroxyquinolinate Inducer 99.86% 否
HY-101902 Quin-2AM / 否
HY-100718 SCH00013 Activator / 否
HY-101015 (2E)-OBAA / 否
HY-101428 NS-638 Inhibitor 99.84% 否
HY-101693A Senazodan hydrochloride Inhibitor 99.84% 否
HY-10388 TTA-Q6 Antagonist 99.97% 否
HY-104056 Fura Red / 否
HY-107659 YM-244769 hydrochloride Inhibitor 98.09% 否
HY-107678 SEN12333 Agonist 98.45% 否
HY-107855S DL-Mevalonolactone-d7 99.27% 否
HY-111014 VK-II-36 Activator 99.63% 否
HY-112741 SB-209247 Antagonist 99.33% 否
HY-113037CS Farnesyl pyrophosphate-d2 triammonium Agonist 95.78% 否
HY-113970A Nebracetam hydrochloride 99.0% 否
HY-115745 Calmodulin antagonist-1 Antagonist 98.0% 否
HY-120514 JNc-440 98.04% 否
HY-120528 GB-110 Agonist / 否
HY-121604 (Rac)-MEM 1003 Inhibitor 99.64% 否
HY-12550 GW542573X Activator 98.79% 否
HY-129146S Doxapram-d5 hydrochloride Inhibitor 99.0% 否
HY-131040 NLRP3-IN-NBC6 Inhibitor 99.40% 否
HY-135110 Rp-8-Br-cGMPS sodium 99.9% 否
HY-13617 Edatrexate / 否
HY-136395 Cartap Inducer / 否
HY-145384 ROC-0929 Inhibitor 99.62% 否
HY-147005 piCRAC-1 Inhibitor 98.24% 否
HY-147384 CXL-1020 ≥99.0% 否
HY-148135 hCAI/II-IN-6 Inhibitor 98.0% 否
HY-149301 hCAIX-IN-18 Inhibitor 98.52% 否
HY-15015 OT-R antagonist 1 Antagonist ≥98.0% 否
HY-151916 Enpp/Carbonic anhydrase-IN-1 99.57% 否
HY-15293A JTV-519 free base Inhibitor / 否
HY-15671A GKA50 quarterhydrate Activator ≥98.0% 否
HY-16147 Combretastatin A1 phosphate 98.00% 否
HY-16489A Terodiline hydrochloride Antagonist 99.78% 否
HY-169332 Piezo1 agonist 1-d2 / 否
HY-170360 UCB9386 Inhibitor 99.89% 否
HY-176745 SW016789 Inducer 99.85% 否
HY-19857 Sulcardine sulfate / 否
HY-B0561S4 Spironolactone-d6-1 / 否
HY-B1873 Methoxychlor Inducer 99.41% 否
HY-D0121A INDO 1 pentapotassium 96.43% 否
HY-DY1028 Fluo-4 AM (solution) / 否
HY-N0126R Xanthone (Standard) Inhibitor 99.99% 否
HY-N0215S14 L-Phenylalanine-15N,d8 Antagonist 99.90% 否
HY-N0252A Catharanthine Tartrate Inhibitor 98.88% 否
HY-N10772 Albanin A Inhibitor 97.67% 否
HY-N16129 Diplacone 98.38% 否
HY-N2359 Chelerythrine / 否
HY-N4267 Yangambin Inhibitor 98.27% 否
HY-N7875 Celangulin 95.93% 否
HY-P0271 Syntide 2 / 否
HY-P1079 ω-Agatoxin TK Inhibitor ≥99.0% 否
HY-P1080 ω-Agatoxin IVA Inhibitor / 否
HY-P11205A Cys-PKHB1 TFA Activator 99.43% 否
HY-P11292 Caloxin 1b3 Inhibitor / 否
HY-P1424A Lei-Dab7 TFA Inhibitor 99.75% 否
HY-P1479A Calmodulin-Dependent Protein Kinase II(290-309) acetate 98.45% 否
HY-P3037 Imperatoxin A Activator / 否
HY-P3965A 16-38-Thymosin β4 (cattle) (TFA) Activator 98.14% 否
HY-P5154A Tamapin TFA Antagonist 98.79% 否
HY-P5914 Wasabi Receptor Toxin Activator / 否
HY-P5988 N-myristoyl-RKRTLRRL Inhibitor 99.37% 否
HY-P6013A wt hMLN TFA Inhibitor 95.0% 否
HY-Q40876 BBT Modulator 99.71% 否
HY-RS01776 CA9 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS11007 PPP2CA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-W170020 PTCA Ligand 99.72% 否
HY-W250149 Chlorophosphonazo III / 否
HY-W748509 Pipernonaline 99.30% 否
HY-101329S Anthracene-9-carboxylic acid-d9 98.94% 否
HY-101693 Senazodan Inhibitor / 否
HY-113040A (17R,18S)-Epoxyeicosatetraenoic acid Inhibitor 93.0% 否
HY-12962 NMDA-IN-1 Antagonist 98.98% 否
HY-137172 ETH 157 / 否
HY-154924 Thio-NADP 96.57% 否
HY-156663 Calcium Channel antagonist 2 Antagonist 98.0% 否
HY-70037AS Cinacalcet-d3 hydrochloride Agonist 97.63% 否
HY-B2217D Calcium hydroxide, ACS, 95% Inhibitor / 否
HY-I0096R Indole-2-carboxylic acid (Standard) Inhibitor 99.78% 否
HY-N0215S L-Phenylalanine-d7 Antagonist 99.90% 否
HY-RS10523 PIK3CA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS21174 Ppp2ca Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-W587805 Perfluorohexane sulfonamide Inhibitor 81.50% 否
HY-132191 Pradimicin A Inhibitor / 否
HY-113308AS Taurolithocholic acid-d4 sodium Agonist 99.4% 否
HY-114400A TRPV4 agonist-1 Agonist / 否
HY-137708 3'2'-cGAMP Activator / 否
HY-169964 TSPO/Carbonic Anhydrase Modulator 1 Modulator / 否
HY-B0551S Doxapram-d8 Inhibitor 99.54% 否
HY-B0782S1 Acetazolamide-13C2,d3 / 否
HY-102085 11-Deoxyglycyrrhetinic acid sodium Activator / 否
HY-103309A ML218 hydrochloride Inhibitor / 否
HY-125836 CCR4 antagonist 2 Antagonist / 否
HY-19805A STO-609 acetate Inhibitor / 否
HY-N1584B Halofuginone hydrochloride / 否
HY-B0632S Diltiazem-d6 Antagonist / 否
HY-N1369S Menthol-d4 / 否
HY-P2471 Neurogranin (48-76), mouse Inhibitor / 否
HY-10050 CJ-17493 Antagonist / 否
HY-100781 D-AP4 Antagonist / 否
HY-100783A (+)-Bicuculline methochloride Antagonist / 否
HY-100783B Bicuculline methobromide Antagonist / 否
HY-100843 L-AP6 / 否
HY-100981 MR-16728 hydrochloride / 否
HY-10167 Tecalcet Modulator / 否
HY-101685A Iganidipine di(hydrochloride) Antagonist / 否
HY-103078A I-XW-053 sodium Inhibitor / 否
HY-103277 BIM 23042 Antagonist / 否
HY-103309S ML218-d9 Inhibitor / 否
HY-103313 SR33805 oxalate Antagonist / 否
HY-103320 Calhex 231 Antagonist / 否
HY-103545 GIP (1-39) Agonist / 否
HY-103660S 18:0 LYSO-PE-d35 / 否
HY-105118 Zaldaride Inhibitor / 否
HY-105402 T 162559 Inhibitor / 否
HY-105415 U 92032 Inhibitor / 否
HY-106428 Icrocaptide Inhibitor / 否
HY-106525 Aclatonium napadisylate Agonist / 否
HY-106761 Oxodipine Antagonist / 否
HY-106818A Monatepil maleate / 否
HY-106837 Israpafant Antagonist / 否
HY-107855S1 DL-Mevalonolactone-d3 / 否
HY-108163A SB-237376 / 否
HY-109106B (Rac)-Upacicalcet 95.0% 否
HY-111198 YM-355179 fumarate / 否
HY-111214 K-14585 / 否
HY-112393 TX-1918 Inhibitor / 否
HY-112794 Topanol CA 98.11% 否
HY-113308AS2 Taurolithocholic acid-d4-1 sodium Agonist / 否
HY-113658 ts-SA / 否
HY-113920 Azumolene sodium Inhibitor / 否
HY-114691 R 59494 Inhibitor / 否
HY-114743 GS 283 Antagonist / 否
HY-114826 Prostaglandin E2-1-glyceryl ester Activator / 否
HY-114990 EMD 57439 Inhibitor / 否
HY-115493 TIQ-15 Antagonist / 否
HY-115767 (±)-1,2-Diolein Activator / 否
HY-115998 Carbonic anhydrase inhibitor 11 Inhibitor / 否
HY-115999 Carbonic anhydrase inhibitor 12 Inhibitor / 否
HY-116153 HUHS2002 / 否
HY-116312 8-pCPT-2′-O-Me-cAMP Activator / 否
HY-116330 Hyperforin / 否
HY-116429A 7(S)-Maresin 1 / 否
HY-116429S Maresin 1-d5 Inhibitor / 否
HY-116500A AH-1058 Antagonist / 否
HY-117099 TMB-8 Antagonist / 否
HY-117578 KB 5666 / 否
HY-118387 AVE-0118 Inhibitor / 否
HY-119386 SAS-0132 / 否
HY-119492 Phenchlobenpyrrone / 否
HY-119919 Clofenamide Inhibitor / 否
HY-120321 DSR-71167 / 否
HY-120355 AP14145 Inhibitor / 否
HY-120699 RO5488608 Modulator / 否
HY-120764 PF-46396 Inhibitor / 否
HY-120820 LY320954 Antagonist / 否
HY-120985 Araguspongin B Antagonist / 否
HY-121299 m-Chlorophenylbiguanide ≥90.0% 否
HY-121516 CM-TPMF / 否
HY-12153 JNJ-1930942 Modulator / 否
HY-12155 JNJ-26990990 Inhibitor / 否
HY-121690 Semotiadil Antagonist / 否
HY-121966 Riparin 98.00% 否
HY-123659 KR-33028 Inhibitor / 否
HY-124176 L-6355 / 否
HY-124985 VU6010608 Modulator / 否
HY-12542S Dantrolene-13C3 Inhibitor 99.0% 否
HY-125641A AL-34662 formate Agonist / 否
HY-125942 SKF-96365 99.97% 否
HY-12596 JNJ-26489112 / 否
HY-126821 Fluo-3 / 否
HY-126821A Fluo-3 pentaammonium / 否
HY-129088 HUP30 99.68% 否
HY-129547 Fluo-3 pentapotassium / 否
HY-12962A NMDA-IN-1 dihydrochloride Antagonist / 否
HY-129781 L-650719 Inhibitor / 否
HY-130070 QO-40 Activator 98.77% 否
HY-130368 W-7 / 否
HY-131001 DPNB-ABT594 Agonist / 否
HY-131041 Ned-K / 否
HY-131942 sFTX-3.3 Antagonist / 否
HY-132190 Hexanolamino PAF C-16 Antagonist / 否
HY-132239 5-Bromo-6-chloro-3-indolyl β-D-Galactopyranoside contains ca. 10% Ethyl Acetate / 否
HY-133596 12,14-Dichlorodehydroabietic acid / 否
HY-135433 MAPTAM / 否
HY-135478 LY393615 Inhibitor / 否
HY-135601 Cinacalcet metabolite M4 / 否
HY-135746S OR-1896-d3 / 否
HY-136189 UK-59811 hydrochloride Inhibitor / 否
HY-136283 DMNPE-4 AM-caged-calcium Ligand / 否
HY-136894 Rhod-5N / 否
HY-137203 (+)-Niguldipine / 否
HY-13764A dl-Tetrandrine Inhibitor / 否
HY-137952 NS8593 Inhibitor / 否
HY-138302 PF-06862309 / 否
HY-138951 AY77 Agonist / 否
HY-138990 GK563 Inhibitor / 否
HY-139041 Palmitoylcholine chloride Inhibitor 99.52% 否
HY-139145 Etbicyphat Antagonist 98.0% 否
HY-139145S Etbicyphat-13C3 / 否
HY-141564 RyR1-IN-1 Inhibitor / 否
HY-141712 ZA18 Inhibitor / 否
HY-141713 ZA10 Inhibitor / 否
HY-142050 (R)-IDHP / 否
HY-142087 Beauverolide Ja Inhibitor / 否
HY-142117 Adenophostin A Activator / 否
HY-143460 CAXII-IN-1 Inhibitor / 否
HY-144222 NSC 828467 Inhibitor / 否
HY-144807 Carbonic anhydrase inhibitor 9 Inhibitor / 否
HY-145196 RTICBM-189 Modulator 99.73% 否
HY-145385 Coelenteramide / 否
HY-145542S Isovalerylcarnitine-d9 chloride / 否
HY-145900 S100A2-p53-IN-1 Inhibitor / 否
HY-146010 Carbonic anhydrase inhibitor 13 Inhibitor / 否
HY-146232 F 13714 Agonist / 否
HY-146252 hCAXII-IN-4 Inhibitor / 否
HY-146259 hCAIX/XII-IN-4 Inhibitor / 否
HY-146461 Anticancer agent 58 / 否
HY-146462 Anticancer agent 59 / 否
HY-14656S1 Diltiazem-(acetoxy-d3) hydrochloride Antagonist / 否
HY-146819 CAIX/CAXII-IN-1 / 否
HY-146982 hCAII-IN-1 Inhibitor / 否
HY-146983 hCAIX-IN-3 Inhibitor / 否
HY-147186 5,5'-Difluoro BAPTA / 否
HY-147377 N-Salicyloyltryptamine 96.37% 否
HY-147383 NS-8 Activator / 否
HY-149011 CA IX-IN-1 Inhibitor / 否
HY-149342 α-Glucosidase-IN-29 Inhibitor / 否
HY-150039 CCG-271423 Inhibitor / 否
HY-15016 (E/Z)-OT-R antagonist 1 Antagonist / 否
HY-15018A SSR126768A free base Antagonist / 否
HY-150536 EP39 Inhibitor / 否
HY-150570 Carbonic anhydrase inhibitor 14 Inhibitor / 否
HY-150695 hCAIX/XII-IN-5 / 否
HY-150782 UNC-CA359 Inhibitor / 否
HY-151451 Cav 3.2 inhibitor 2 Inhibitor / 否
HY-151452 Cav 3.2 inhibitor 3 Inhibitor / 否
HY-151472 hCAIX/XII-IN-6 Inhibitor / 否
HY-151493 CAII-IN-1 Inhibitor / 否
HY-151494 CAII-IN-2 Inhibitor / 否
HY-151495 CAII-IN-3 Inhibitor / 否
HY-151547 MRS4719 Antagonist / 否
HY-151547S MRS4719-d3 / 否
HY-151578 DPP IV/hCA II-IN-1 Inhibitor / 否
HY-151633 hCAIX-IN-14 Inhibitor / 否
HY-152140 hCAII-IN-8 Inhibitor 99.41% 否
HY-15293 JTV-519 Inhibitor / 否
HY-155694 hCA/VEGFR-2-IN-1 Inhibitor / 否
HY-156013 CA inhibitor 2 Inhibitor / 否
HY-156082 RyRs activator 3 Inhibitor / 否
HY-156104 CaMKIIα-PHOTAC Degrader / 否
HY-156181 hCAIX/XII-IN-8 Inhibitor / 否
HY-157139 ALP/Carbonic anhydrase-IN-1 Inhibitor 99.90% 否
HY-158328A CA IX/VEGFR-2-IN-2 / 否
HY-159122 CA IX-IN-2 / 否
HY-159861 Ionizable Lipid 4 / 否
HY-160508 NCX1-IN-1 Inhibitor / 否
HY-160962 SM1044 / 否
HY-160998 YM-344031 Antagonist / 否
HY-161143 Carbonic anhydrase/AChE-IN-2 Inhibitor / 否
HY-161388 NSCLC-IN-1 Inducer / 否
HY-162000 hCAIX/XII-IN-13 Inducer / 否
HY-162005 AChE-IN-48 Inhibitor / 否
HY-162063 hCAIX/XII-IN-9 Inhibitor / 否
HY-162280 PROTAC BTK Degrader-9 / 否
HY-162331 STING Degrader-1 Degrader / 否
HY-162344 Ir-CA Inducer / 否
HY-162374 ANO61 Inhibitor / 否
HY-162375 AF299 / 否
HY-162521 Antibacterial agent 215 Inhibitor / 否
HY-162526 HIV capsid modulator 2 Modulator / 否
HY-162774 GRP75-IN-1 Inducer / 否
HY-163116 Anti-inflammatory agent 67 Inhibitor / 否
HY-163117 Anti-inflammatory agent 68 Inhibitor / 否
HY-163380 CA/MAO-B-IN-1 Inhibitor 98.34% 否
HY-164682 AMD 3329 octahydrobromide Inhibitor / 否
HY-164684 Dichlorobenzamil Inhibitor / 否
HY-165492 Opc 14117 Inhibitor / 否
HY-165569 AU-1421 Modulator / 否
HY-166363S Beraprost-d3 / 否
HY-166562S Levomepromazine-d6 hydrochloride / 否
HY-167091 (Rac)-Beraprost / 否
HY-168320 N-Stearoyltyrosine Inhibitor / 否
HY-168603 AChE/CA I-IN-1 Inhibitor / 否
HY-168604 CA Ⅱ-IN-1 Inhibitor / 否
HY-169115A (Rac)-PD0299685 Ligand / 否
HY-169162 hBChE-IN-3 / 否
HY-169209 CA-M11 Inhibitor / 否
HY-169845 Calcium Channel antagonist 6 Antagonist / 否
HY-170424 D-myo-Inositol-1,3,4,5-tetrakisphosphate potassium / 否
HY-170541 FUT8-IN-1 Inhibitor / 否
HY-170551 CA IX/VEGFR-2-IN-3 Inhibitor / 否
HY-170558 FW-1 / 否
HY-170560 AChE/hCA I-IN-1 Inhibitor / 否
HY-170893 CAIX/CAXII-IN-4 Inhibitor / 否
HY-171129 EP055 / 否
HY-172772 Anti-PEDV agent 1 Inhibitor / 否
HY-172899 Carbonic anhydrase inhibitor 33 / 否
HY-172950 CAXII-IN-2 Inhibitor / 否
HY-172964 KIM-161 / 否
HY-173194 Carbonic anhydrase inhibitor 29 Inhibitor / 否
HY-173321 PAD4-IN-5 Inhibitor / 否
HY-173618 LQFM020 / 否
HY-17404S Cilnidipine-d7 Inhibitor / 否
HY-174232 EGFR/CA-IX-IN-1 / 否
HY-174269 HIV Capsid-IN-2 Inhibitor / 否
HY-174835 hCA-I/hCA-II-IN-1 Inhibitor / 否
HY-175021 HDAC-IN-91 / 否
HY-175219 CA-II/Dkk1-IN-1 Inhibitor / 否
HY-175441 Carbonic anhydrase activator 1 Activator / 否
HY-175593 M6766 / 否
HY-175638 Carbonic anhydrase-IN-35 / 否
HY-175675 P2Y1 antagonist 4 / 否
HY-176021 U-44069 serinol amide / 否
HY-176041 Troponin modulator 1 / 否
HY-176147 Apoptosis inducer 38 Inducer / 否
HY-177091 AS2795440 Inhibitor / 否
HY-177296 GPR40 agonist 8 Agonist / 否
HY-177573 Cholesteryl γ-aminobutyrate / 否
HY-178030 CAXII-IN-3 / 否
HY-178144 FPR2 agonist 5 / 否
HY-178251S L-Phenylalanine-d / 否
HY-178437 Bastadins-5 / 否
HY-178475 CA IX/GPX4-IN-1 / 否
HY-178963 Nav1.2-IN-2 Inhibitor 99.82% 否
HY-179016 Ferroptosis/apoptosis inducer-3 / 否
HY-179022 CAIX/CDK-2-IN-1 / 否
HY-179034 CAIX/XII-IN-16 / 否
HY-179271 CA/HDAC-IN-1 Inhibitor / 否
HY-179387 CXCR2-IN-3 / 否
HY-179439 Multi-kinase-IN-8 / 否
HY-179530 CA-II/TNAP-IN-1 Inhibitor / 否
HY-179712 As-CA11 / 否
HY-180056 CAII-IN-12 / 否
HY-180165 Antiallergic agent-5 Inhibitor / 否
HY-180189 Carbonic anhydrase-IN-37 Inhibitor / 否
HY-180194 SERCA2a activator 2 Activator / 否
HY-180244 P2L-003 / 否
HY-18051 CXL 017 / 否
HY-180891 Multitarget AD-IN-4 Inhibitor / 否
HY-181087 Anticancer agent 296 / 否
HY-181587 PDGFRA/CAIX/XII-IN-1 / 否
HY-19025 CV-159 Antagonist / 否
HY-19044 SKF 95601 / 否
HY-19230 DY-9760e Inhibitor / 否
HY-19409 AJG049 Antagonist / 否
HY-34740S1 Ethylmalonic acid-d5 Inhibitor 98.09% 否
HY-44602 Thioaspirine Inhibitor / 否
HY-50876A Daporinad hydrochloride / 否
HY-70037S Cinacalcet-D3 Agonist / 否
HY-A0057AS2 Gabapentin-d4 hydrochloride Inhibitor / 否
HY-B0006CS (R)-Carvedilol-d4 Inhibitor / 否
HY-B0109AS1 Dorzolamide-d5(hydrochloride) Inhibitor / 否
HY-B0246S4 Carbamazepine-d4 99.72% 否
HY-B0358AS Flunarizine-d8 dihydrochloride / 否
HY-B0380S1 Trimebutine-d5 fumarate / 否
HY-B0380S2 Trimebutine-d3 hydrochloride / 否
HY-B0588AS Brinzolamide-d5 hydrochloride / 否
HY-B0596S Taltirelin-13C,d3 / 否
HY-B0684S1 Iopamidol-d3 / 否
HY-B1221S Flufenamic acid-d4 / 否
HY-B1693A Levomepromazine hydrochloride / 否
HY-B1726 Phenacaine Inhibitor 99.68% 否
HY-B1837A β-Cyfluthrin Inhibitor 99.94% 否
HY-B1837AR β-Cyfluthrin (Standard) Inhibitor / 否
HY-CE01249 CA-CoA / 否
HY-D0121 INDO 1 / 否
HY-D0121B INDO 1 pentasodium / 否
HY-D0157 ZnAF-2 / 否
HY-D1424 Coelenterazine hcp / 否
HY-D1501 Fura PE-3 potassium / 否
HY-D1608 BODIPY FL Thapsigargin Inhibitor / 否
HY-D1616 5-Bromo-5'-methyl BAPTA tetramethyl ester / 否
HY-D1631A Calcium green-5N hexapotassium / 否
HY-D1636 5-Nitro BAPTA / 否
HY-D1640 5',5-Difluoro BAPTA tetrapotassium / 否
HY-D1643 5,5'-Dinitro BAPTA AM / 否
HY-D1700 Mag-indo-1/AM / 否
HY-D1702 Mag-Fura-2 tetrapotassium / 否
HY-D1755 Fluo-3FF AM / 否
HY-D2952 BOCA-1-BG / 否
HY-D3030 Concanavalin A-FITC / 否
HY-D3031 Concanavalin A-TRITC / 否
HY-D3032 Concanavalin A-thiol / 否
HY-DY1055 TSQ (solution) / 否
HY-E70197 Calpain-1 (pig) / 否
HY-E70813 CAMKK2 Recombinant Human Active Protein Kinase / 否
HY-E70856 PKCθ Recombinant Human Active Protein Kinase / 否
HY-E70949 Protein Kinase C,Rat / 否
HY-I0096S Indole-2-carboxylic acid-13C Inhibitor / 否
HY-N0043R Ginsenoside Rd (Standard) Inhibitor / 否
HY-N0215S13 L-Phenylalanine-d1 Antagonist 99.5% 否
HY-N0215S6 DL-Phenylalanine-d5 hydrochloride Antagonist / 否
HY-N0215S9 L-Phenylalanine-13C9,15N,d8 Antagonist / 否
HY-N0219R Bicuculline (Standard) Antagonist / 否
HY-N0252B Catharanthine Sulfate Inhibitor / 否
HY-N10512 Gangliotetraose / 否
HY-N11865 Maitotoxin disodium Activator / 否
HY-N11887 Linocinnamarin Inhibitor / 否
HY-N1228 Soyacerebroside I / 否
HY-N12455 Comosone II / 否
HY-N12726 Halociline Inhibitor / 否
HY-N15735 Cimicifugic acid D Inhibitor / 否
HY-N15737 Fukinolic acid Inhibitor / 否
HY-N16525 Muramine / 否
HY-N17738 Acetyljujuboside B / 否
HY-N18431 Stellettamide A TFA Inhibitor / 否
HY-N2359S Chelerythrine-d6 chloride / 否
HY-N3729 (-)-Denudatin B Inhibitor 97.88% 否
HY-N5123 α-L-Rhamnose / 否
HY-N6687C Calcimycin hemicalcium hemimagnesium / 否
HY-N7063R Nerol (Standard) / 否
HY-N7594 Senecionine acetate / 否
HY-N8112 Polygalasaponin LII / 否
HY-NP164A Concanavalin A-Cy5.5 / 否
HY-NP164C Concanavalin A-AF350 / 否
HY-NP164D Concanavalin A-AF405 / 否
HY-NP164E Concanavalin A-AF430 / 否
HY-NP164H Concanavalin A-AF532 / 否
HY-NP164I Concanavalin A-AF546 / 否
HY-NP164J Concanavalin A-AF555 / 否
HY-NP164K Concanavalin A-AF568 / 否
HY-NP164L Concanavalin A-AF647 / 否
HY-NP164M Concanavalin A-AF680 / 否
HY-NP164N Concanavalin A-Cy3 / 否
HY-NP164O Concanavalin A-Cy5 / 否
HY-P0033A Argireline acetate Inhibitor / 否
HY-P0188 ω-Conotoxin MVIIC Inhibitor / 否
HY-P0189 ω-Conotoxin GVIA Inhibitor / 否
HY-P0221A PACAP (1-38), human, ovine, rat TFA Inducer / 否
HY-P10316 CaMKI(299-320) Modulator / 否
HY-P10328 Vasoactive intestinal contractor Inhibitor / 否
HY-P10371 PKHB1 Activator / 否
HY-P1075A CALP3 TFA Inhibitor / 否
HY-P1076 CALP2 Antagonist / 否
HY-P10773 CTP-amiodarone Inhibitor / 否
HY-P10805 Capsid assembly inhibitor Inhibitor / 否
HY-P10811 Na2+ - Ca2+ Exchanger inhibitory peptide Inhibitor / 否
HY-P10972 GIP (22-51) human / 否
HY-P11019 IS4 Antagonist / 否
HY-P11082 APGW-amide / 否
HY-P11205 Cys-PKHB1 Activator / 否
HY-P11252 DOTA-CA-170 Ligand / 否
HY-P11253 DOTA-Bn-CA-170 / 否
HY-P11405 [D-Arg1,D-Trp5,7,9,Leu11]-Substance P Antagonist / 否
HY-P1247A Calcineurin autoinhibitory peptide TFA Inhibitor / 否
HY-P1250A RFRP-3(human) TFA Agonist / 否
HY-P1345 TLQP-21 Agonist / 否
HY-P1366A des-​Gln14-​Ghrelin TFA / 否
HY-P1437A Neuropeptide S(Mouse) TFA Agonist / 否
HY-P2424 Cholecystokinin-J / 否
HY-P2722 Bovine brain Calcineurin / 否
HY-P3089 Dendrotoxin K Inhibitor / 否
HY-P3168 Martentoxin Inhibitor / 否
HY-P3187A exo-β-1,4-xylosidase, Clostridium stercorarium / 否
HY-P3187B exo-β-1,4-xylosidase, Bacteroides ovatus / 否
HY-P3316 OSK-1 Inhibitor / 否
HY-P3679 Neuropeptide Y (1-24) (human) Activator / 否
HY-P3811 Autocamtide-3 / 否
HY-P3943 Calmodulin Dependent Protein Kinase Substrate Analog / 否
HY-P3944 Calmodulin Dependent Protein Kinase Substrate / 否
HY-P4368 Z-APF-CMK Inhibitor / 否
HY-P4397 (d(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin / 否
HY-P5154 Tamapin Antagonist / 否
HY-P5319 MCaE12A / 否
HY-P5422 Caloxin 3A1 Inhibitor / 否
HY-P5796 FS-2 Inhibitor / 否
HY-P5799 ω-Conotoxin MVIID Inhibitor / 否
HY-P5802 ω-Conotoxin FVIA Inhibitor / 否
HY-P5805 ω-Conotoxin CVIE Inhibitor / 否
HY-P5813 Cd1a Inhibitor / 否
HY-P5869 Kurtoxin / 否
HY-P5870 KTX-Sp2 Inhibitor / 否
HY-P6008 Myoregulin / 否
HY-P6008A Myoregulin TFA / 否
HY-P6013 wt hMLN Inhibitor / 否
HY-P6292 KS-133 Antagonist 98.75% 否
HY-RS01762 CA1 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01763 CA10 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01764 CA11 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01765 CA12 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01766 CA13 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01767 CA14 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01768 CA2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01769 CA3 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01770 CA4 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01771 CA5A Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01772 CA5B Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01773 CA6 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01774 CA7 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01775 CA8 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01850 CALY Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10524 Pik3ca Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10525 Pik3ca Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS10973 PPP1CA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS11023 PPP3CA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-U00026 Semotiadil recemate fumarate / 否
HY-W040028 Cartap hydrochloride Inducer / 否
HY-W069974 Ca2+ -Langerin-IN-1 / 否
HY-W1049761 Ti-MUV-10(Ca) / 否
HY-W127795 Fluo-3 ammonium / 否
HY-W250153A Adenosine 3'-phosphate 5'-phosphosulfate lithium, hydrate Antagonist / 否
HY-W272201 Catechol diacetate Inhibitor / 否
HY-W339833 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphate sodium / 否
HY-W403046A D-myo-Inositol-4-phosphate monoammonium Activator / 否
HY-W414824 3β,7β-Dihydroxy-5-cholestenoic acid / 否
HY-W424792A O-Desmethyl Brinzolamide hydrochloride Inhibitor / 否
HY-W565924 STX107 / 否
HY-W707161 4-Methyl-2-(1-piperidinyl)-quinoline-d10 / 否
HY-W710915 Aprindine hydrochloride-d10 Inhibitor / 否
HY-W711474 (-)-Menthol-d4 / 否
HY-W721517 Gabapentin-d10 / 否
HY-W783254 C18 LPA / 否
HY-W838171 Tiaramide / 否
HY-Z8176 (Z)-Flunarizine Inhibitor / 否
HY-101136 Dealanylascamycin Inhibitor / 否
HY-101616 ABT-639 hydrochloride Inhibitor / 否
HY-101669 TDN345 Antagonist / 否
HY-101685 Iganidipine Antagonist / 否
HY-101727 Nexopamil racemate / 否
HY-10341D Fasudil mesylate / 否
HY-108163 SB-237376 free base Antagonist / 否
HY-108984 BBMP / 否
HY-109559 Pentetate calcium trisodium / 否
HY-110091 TRPV1 antagonist 9 Antagonist / 否
HY-113037AS Farnesyl pyrophosphate-d6 Agonist / 否
HY-113308AS1 Taurolithocholic Acid-d5 sodium salt Agonist / 否
HY-113723 MRS2298 Antagonist / 否
HY-115231 ci-IP3/PM / 否
HY-115767S (±)-1,2-Diolein-13C3 Activator / 否
HY-116072 Antiarrhythmic agent-2 Inhibitor / 否
HY-116143 MAGL-IN-12 Inhibitor / 否
HY-116191 WJD008 Inhibitor / 否
HY-116723 CFMMC Antagonist / 否
HY-117055 Ro 18-3981 Inhibitor / 否
HY-117982 SKI2496 / 否
HY-121186S Bevantolol-d7 hydrochloride Antagonist / 否
HY-121366 Kadethrin Inhibitor / 否
HY-121720 L 657925 Antagonist / 否
HY-121914 (2-Chlorophenyl)diphenylmethanol Inhibitor 99.56% 否
HY-123434 PD-149164 Agonist / 否
HY-126821B Fluo-3 sodium / 否
HY-129334 Macrocalin B Inhibitor / 否
HY-130358 PDDHV Activator / 否
HY-131764 2'-O-MB-cGMP sodium Inhibitor / 否
HY-133614 Dihydroisopimaric acid Activator / 否
HY-134368 Ap3A Inhibitor / 否
HY-135110A Rp-8-Br-cGMPS / 否
HY-135317C Emavusertib tosylate / 否
HY-135317D Emavusertib mesylate / 否
HY-135317E Emavusertib maleate / 否
HY-135317F Emavusertib phosphate / 否
HY-135478A LY393615 free base Inhibitor / 否
HY-137162 Dotarizine Inhibitor / 否
HY-141613A Dioleyl phosphatidylserine Activator / 否
HY-14477 UPF-1035 Inhibitor / 否
HY-14656S2 Diltiazem-d6 hydrochloride Antagonist / 否
HY-147301B Resomelagon methanesulfonate Agonist / 否
HY-149779 RyR2 stabilizer-1 Modulator / 否
HY-152051S Mabuterol-d9 hydrochloride Agonist / 否
HY-157321 hCAI/II-IN-7 Inhibitor 99.80% 否
HY-159870 E12CA1A3 / 否
HY-161848 TCP-MP-CA Inhibitor / 否
HY-163660 Carbonic anhydrase inhibitor 23 Inhibitor / 否
HY-164090 Adenosine 3'-phosphate 5'-phosphosulfate Antagonist / 否
HY-164631 EL20 Inhibitor / 否
HY-167203 AJG049 free base Antagonist / 否
HY-168377 Fluo-4 potassium / 否
HY-168382 5R(6S)-EET Agonist / 否
HY-168382A 5S(6R)-EET Agonist / 否
HY-168767 CA IX-IN-3 Inhibitor / 否
HY-169206 PF-3166 Inhibitor / 否
HY-16935S Mavatrep-d6 Antagonist / 否
HY-169780 (S)-AMG-628 Antagonist / 否
HY-171187 Chlorzolamide Inhibitor / 否
HY-171469 SKP-451 Agonist / 否
HY-172321 Etheno-NAADP sodium / 否
HY-17404S1 Cilnidipine-d4 Inhibitor / 否
HY-174685 Human FLI1 mRNA / 否
HY-174829 7,4'-Dimethoxy-3-hydroxyflavone / 否
HY-180864 CA12 modulator-1 / 否
HY-19062 SM-6586 / 否
HY-A0082S Diphenidol-d10 hydrochloride Antagonist / 否
HY-B0021S1 Doxifluridine-d3 Inhibitor / 否
HY-B0109AS Dorzolamide-d3 hydrochloride Inhibitor / 否
HY-B0109S Dorzolamide-d5 Inhibitor / 否
HY-B0493S Niflumic Acid-d5 Inhibitor / 否
HY-B0632B (2R,3R)-Diltiazem hydrochloride Inhibitor / 否
HY-B0632S2 Diltiazem-d4 Inhibitor / 否
HY-B0684S Iopamidol-d8 / 否
HY-B1193S Terfenadine-d3 / 否
HY-D0110B Fura-2 pentasodium / 否
HY-N0081A (-)-Praeruptorin A Inhibitor / 否
HY-N10754 Aschantin Inhibitor / 否
HY-N12164 Linearmycin B Inhibitor / 否
HY-N1369S1 Menthol-d2 Modulator / 否
HY-N13916 Alternaric acid / 否
HY-N14440 Furaquinocin C / 否
HY-N7063S Nerol-d2 / 否
HY-N7063S1 Nerol-d6 / 否
HY-N9422 Adenosine 3'-phosphate 5'-phosphosulfate triethylamine Antagonist / 否
HY-N9484S Menthofuran-13C2 / 否
HY-N9485 25(R)-Hydroxyprotopanaxadiol / 否
HY-RS19521 Ppp3ca Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS20700 Caly Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS26016 Ppp3ca Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS27211 Caly Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS27691 Ppp2ca Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-W002006 6-Amino-1,3-dimethyluracil / 否
HY-W150752 Triphenylethylene 99.86% 否
HY-W250153 Adenosine 3'-phosphate 5'-phosphosulfate lithium Antagonist / 否
HY-W288025 ALXR-agonist-6 Agonist / 否
HY-W587689 Juvenile hormone B 3 (mixture of diastereomers) / 否
HY-W653978 Cinacalcet-d4 hydrochloride Agonist / 否
HY-W654243 Isovalerylcarnitine-d9-1 chloride Activator / 否
HY-W755295 Mabuterol hydrochloride Agonist / 否
HY-W931056 AMG-628 Inhibitor / 否
HY-P1479 Calmodulin-Dependent Protein Kinase II (290-309) / 否
HY-U00354 CP-060 Antagonist / 否
抗体抑制剂 (3)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P991649 Anti-CA6 Antibody (huDS6) 98.03% 否
HY-P990830 Anti-MUC16 Antibody (VK8) Inhibitor / 否
HY-P991646 ING-1 / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Caly NCBI NCBI:50632
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z